Honyi International Company Limited (TPEX:4530)
12.55
+0.20 (1.62%)
Aug 1, 2025, 1:30 PM CST
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -62.75 | -69.59 | -62.16 | -13.33 | -21.85 | -22.73 | Upgrade |
Depreciation & Amortization | 30.09 | 31.74 | 30.17 | 27.51 | 26.61 | 9.19 | Upgrade |
Other Amortization | 0.07 | 0.05 | 0.05 | 0.02 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 4.03 | 3.86 | 9.66 | -0.1 | -8.14 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 31.15 | 31.15 | 3.6 | - | 5.35 | 8.29 | Upgrade |
Loss (Gain) From Sale of Investments | 0.09 | 0.01 | 0 | 0.05 | 0.02 | -0.01 | Upgrade |
Loss (Gain) on Equity Investments | 2.45 | 4.52 | 3.38 | 0.81 | 0.7 | 0.77 | Upgrade |
Provision & Write-off of Bad Debts | -0.07 | -0.24 | 0.35 | - | 0.05 | - | Upgrade |
Other Operating Activities | 12.05 | 9.41 | 1.2 | 3.33 | 2.88 | 0.22 | Upgrade |
Change in Accounts Receivable | 5.84 | -0.42 | 1.45 | 4.8 | 5.35 | 0.18 | Upgrade |
Change in Inventory | -2.04 | -1.41 | 0.64 | -4.67 | -1.18 | -1.83 | Upgrade |
Change in Accounts Payable | -11.28 | 0.42 | -1.39 | -0.86 | -10.23 | -0.23 | Upgrade |
Change in Unearned Revenue | 12.12 | -0.18 | -0.04 | -2.51 | -2.91 | 0.02 | Upgrade |
Change in Other Net Operating Assets | -24.72 | 8.94 | -0.46 | 6.8 | 0.6 | -2.06 | Upgrade |
Operating Cash Flow | -3.9 | 18.26 | -13.55 | 21.85 | -2.77 | -8.18 | Upgrade |
Capital Expenditures | -1.01 | -1.59 | -16.47 | -67.13 | -19.35 | -2.27 | Upgrade |
Sale of Property, Plant & Equipment | 0.85 | 0.8 | 2.23 | 0.1 | - | - | Upgrade |
Cash Acquisitions | 143.36 | - | - | - | 17.83 | - | Upgrade |
Divestitures | - | - | - | - | 11.07 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.31 | -0.31 | -0.32 | -0.3 | - | - | Upgrade |
Investment in Securities | -111 | -109 | 9.9 | 19.39 | 22.23 | -40.04 | Upgrade |
Other Investing Activities | 6.42 | 0.86 | -0.42 | -0.14 | -0.92 | 0.19 | Upgrade |
Investing Cash Flow | 38.31 | -109.24 | -5.08 | -48.08 | 30.86 | -42.12 | Upgrade |
Long-Term Debt Issued | - | - | - | 16.99 | - | - | Upgrade |
Total Debt Issued | - | - | - | 16.99 | - | - | Upgrade |
Long-Term Debt Repaid | - | -10.32 | -18.23 | -11.84 | -13.06 | -4.33 | Upgrade |
Total Debt Repaid | -21.36 | -10.32 | -18.23 | -11.84 | -13.06 | -4.33 | Upgrade |
Net Debt Issued (Repaid) | -21.36 | -10.32 | -18.23 | 5.15 | -13.06 | -4.33 | Upgrade |
Issuance of Common Stock | 152 | 152 | - | - | 21.06 | - | Upgrade |
Other Financing Activities | -4.94 | -4.85 | -4.08 | -1.74 | -2.7 | - | Upgrade |
Financing Cash Flow | 125.7 | 136.83 | -22.31 | 3.41 | 5.3 | -4.33 | Upgrade |
Net Cash Flow | 160.12 | 45.85 | -40.94 | -22.83 | 33.4 | -54.62 | Upgrade |
Free Cash Flow | -4.91 | 16.67 | -30.03 | -45.28 | -22.12 | -10.44 | Upgrade |
Free Cash Flow Margin | -2.36% | 9.47% | -18.54% | -23.02% | -13.85% | -27.90% | Upgrade |
Free Cash Flow Per Share | -0.08 | 0.31 | -0.61 | -0.92 | -0.48 | -0.23 | Upgrade |
Cash Interest Paid | 0.92 | 1 | 1.65 | 1.51 | 1.12 | 0.37 | Upgrade |
Cash Income Tax Paid | 1.29 | 1.29 | 2.97 | 2.2 | 0.6 | -0.22 | Upgrade |
Levered Free Cash Flow | 19.51 | 30.68 | -14.89 | -43.83 | -1.52 | -6.03 | Upgrade |
Unlevered Free Cash Flow | 20.08 | 31.3 | -13.86 | -42.89 | -0.82 | -5.8 | Upgrade |
Change in Net Working Capital | 4.61 | -9.91 | 1.51 | -4.57 | -9.87 | 3.82 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.